Patients with metastatic lung cancer harboring epidermal growth factor receptor mutations represent a very relevant subgroup of lung cancer patients because they are never smokers in the majority of the cases and for very good therapeutic outcomes. The gene discussed is EGFR; the disease is lung cancer.